Home Visit
Upload
CD79a IHC
No special precautions
Recommended for
Male, Female
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
The CD79a IHC test is a laboratory procedure that uses antibodies to detect the presence of CD79a, a protein found on the surface of B cells, a type of white blood cell that plays a crucial role in the immune system. B cells are responsible for producing antibodies, which are proteins that recognize and bind to specific foreign invaders, such as bacteria and viruses. CD79a is expressed on the surface of most B cells, making it a valuable marker for distinguishing between B-cell lymphomas and other types of cancer.
CD79a IHC Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the CD79a IHC with a clear pricing structure.
The CD79a IHC Price in Mumbai is ₹ 2,545 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
This test measures the expression and quantity of the CD79a protein in tissue samples.
The CD79a test is done for the following reasons:
- To aid in the diagnosis and classification of B-cell lymphomas and leukaemias
- To guide treatment decisions based on the specific type of haematological malignancy
- To monitor the progress and response to treatment in patients with known B-cell malignancies
- The CD79a test is recommended for individuals who show signs or symptoms suggestive of B-cell lymphomas or leukaemias, such as unexplained weight loss, fatigue, swollen lymph nodes, night sweats, or abnormal blood counts.
- This test is also useful for patients with a previous diagnosis of B-cell malignancies.
- A family history of B-cell lymphoma
Abnormal results may indicate the presence of B-cell lymphomas. However, an abnormal result does not provide a definitive diagnosis. It is important to discuss your test results with your doctor, who will consider your medical history, symptoms, and other diagnostic tests to provide an accurate interpretation.
- A small tissue sample will be collected for analysis.
- The sample will be sent to the laboratory for testing.
- The CD79a protein levels will be assessed using the immunohistochemistry (IHC) method.
Before the CD79a test:
- You may need to provide your original histopathology report and relevant clinical and radiological details.
- If you have a scheduled biopsy or surgical procedure, follow your doctor's instructions regarding fasting, medications, and any specific preparation needed for the procedure.
- Immunohistochemistry panel: A panel of markers to further classify B-cell lymphomas and leukaemia
- Flow cytometry: This test evaluates markers on cells in suspension and aids in the diagnosis and classification of various haematological malignancies.
- CD79a immunohistochemistry
- CD79a IHC
- CD79a immunostaining
- CD79a antibody staining
- CD79a marker test
B-cell lymphoma is a type of cancer that originates in B-cells, a type of white blood cell responsible for producing antibodies. It leads to the uncontrolled growth of abnormal B-cells, causing the formation of tumours in lymph nodes or other organs. Early diagnosis through tests like CD79a helps guide treatment decisions and improves patient outcomes.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp